Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Medipattern, a Canadian developer of medical software solutions, and Navix Diagnostix, a provider of vascular ultrasound outsourcing solutions, have signed an agreement under which Navix will collect data for the development of Medipattern's vascular imaging tool, VasculariQ.
Subscribe to our email newsletter
Medipattern has recently signed an agreement with GE Healthcare to create a set of image quantification tools to help physicians visualize plaque and other conditions that can block the vascular system.
Jeff Collins, CEO of The Medipattern, said: Under the agreement with GE Healthcare, GE and Medipattern have been working on a proof of concept for the vascular quantification tool that we shared with Bob Kane and his colleagues at Navix.
GE Healthcare’s Vascular Ultrasound team is committed to developing new technology to image and analyze vascular disease, increasing diagnostic confidence and speeding patient treatment.
Medipattern recently announced an agreement with GE Healthcare to create a set of image quantification tools to help physicians visualize plaque and other conditions that can block the vascular system.
Navix Diagnostix is a privately held company, which provides cardiovascular management solutions for hospitals and medical practices.
Medipattern is a pharmaceutical company, which focuses on the development of medical software solutions that help improve imaging workflow and productivity. Medipattern uses its Cadenza(TM) CAD Technology to power the digital conversion in medical communications.